What Is Cell Therapy? A Plain-English Guide for 2026
Ever asked yourself what is a cell therapy and why it’s suddenly everywhere in the news? This plain-English 2026 guide breaks down the science from the ground up, covering uses beyond cancer and how to spot a legitimate, FDA-approved treatment versus an unproven clinic offering.
Myeloma CAR T-Cell Therapy in 2026: Why Timing Matters Most
As myeloma CAR T-cell therapy moves into earlier treatment lines in 2026, timing has become the key factor determining patient access and outcomes. This article breaks down the clinical debates—from trial data to capacity constraints—into a clear framework for knowing when the referral conversation should start.
Multiple Myeloma CAR T-Cell Therapy: Your Referral Roadmap for 2026
Multiple myeloma CAR T-cell therapy is now recommended earlier than ever, making timely referrals critical for patients. This 2026 roadmap walks you through when to ask about CAR-T, what to expect next, and how to prepare logistically and financially for treatment.